Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 03/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 01/03/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | +8.34% | +53.87% | +155.75% | 1,070B | |
| -1.76% | +6.23% | +66.27% | +53.44% | 611B | |
| -1.05% | +7.19% | +35.57% | +86.77% | 445B | |
| -2.10% | +4.18% | +31.11% | +23.88% | 329B | |
| -0.01% | +1.35% | +35.53% | +35.90% | 290B | |
| -0.78% | +1.24% | +28.58% | +42.17% | 287B | |
| +0.87% | +1.93% | -27.56% | -41.34% | 213B | |
| +0.44% | +4.35% | +29.69% | +63.10% | 195B | |
| +0.01% | +1.03% | +13.95% | +63.93% | 157B | |
| Average | -0.25% | +5.04% | +29.67% | +53.73% | 399.58B | |
| Weighted average by Cap. | -0.33% | +6.67% | +40.26% | +78.35% |
